International Journal of Gynecology & Obstetrics
Volume 86 , Pages S25-S37 , July 2004

Clinical practice guidelines on the initial assessment and treatment of urinary incontinence in women: a US focused review

  • Lars Viktrup

      Affiliations

    • Clinical Research Physician at Eli Lilly Research Laboratories, Eli Lilly and Company Faris II, Drop Code 6112, Indianapolis, IN 46285, USA and Research Unit for General Practice, Frederiksborg County, Denmark
    • Corresponding Author InformationCorresponding author. Tel.: +1-3176516219; fax: +1-3172764789
    • ,
  • Kent H Summers

      Affiliations

    • Associate Professor, Department of Pharmacy Practice, Purdue University School of Pharmacy, West Lafayette, IN, USA
    • ,
  • Susan L Dennett

      Affiliations

    • President, Strategic Health Outcomes, Carmel, IN, USA

References 

  1. National Institutes of Health. National Institute of Diabetes and Digestive and Kidney Diseases. Overcoming Bladder Disease. A Strategic Plan for Research. Urinary Incontinence: Common Clinical Conditions. A report of the bladder research progress review group. 2002. Accessed October 13, 2003 at http://www.niddk.nih.gov/fund/other/brprg_book.pdf
  2. Diokno AC, Burgio K, Fultz NH, Kinchen K, Obenchain R, Bump R. Medical and self-care practices reported by women experiencing urinary incontinence. Am J Managed Care. 2004;10(part 1):69–78
  3. Hunskaar S, Lose G, Sykes D, Voss S. The prevalence of urinary incontinence in women in four European countries. Br J Urol Int. 2004;93:324–330
  4. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al.  The standardisation of terminology in lower urinary tract function: Report from the standardisation subcommittee of the international continence society. Urology. 2003;62:37–49
  5. Nihira MA, Henderson N. Epidemiology of urinary incontinence in women. Curr Womens Health Rep. 2003;3(4):340–347
  6. Fultz NH, Burgio K, Diokono AC, Kinchen KS, Obenchain R, Bump RC. Burden of stress urinary incontinence for community-dwelling women. Am J Obstet Gynecol. 2003;189(5):1275–1282
  7. Wilson L, Brown JS, Shin GP, Luc K, Subak LL. Annual direct cost of urinary incontinence. Obstet Gynecol. 2001;98:398–406
  8. Kinchen KS, Long S, Orsini L, Crown W, Swindle R. A retrospective claims analysis of the direct costs of stress urinary incontinence. Int Urogynecol J. 2003;14:403–411
  9. Voss S, Lose G, Papanicolaou S, Sykes D, Hunskaar S: How bothersome is urinary incontinence? Results from a study of women in four European countries. Abstract presented at the XIXth Congress of the European Association of Urology, March 24–27, 2004 in Vienna, Austria
  10. McFall S, Yerkes AM, Bernard M, LeRud T. Evaluation and treatment of urinary incontinence. Report of a physician survey. Arch Fam Med. 1997;6:114–119
  11. Hullfish KL, Bovbjerg VE. Medical student exposure to female pelvic floor dysfunction: A survey of new house staff. J Pelvic Med & Surg. 2003;9:37–40
  12. Gordon D, Groutz A. Evaluation of female lower urinary tract symptoms: Overview and update. Curr Opin Obstet Gynecol. 2001;13:521–527
  13. Viktrup L, Bump RC: Assessment of female urinary incontinence in the ob/gyn office. Contemporary OB/GYN 2004 (in press)
  14. Jancin B. Family physicians can treat most cases of urinary incontinence. Fam Pract News. 2001;31:18
  15. Seim A, Hermstad R, Hunskaar S. Female urinary incontinence: long-term follow-up after treatment in general practice. Br J Gen Pract. 1998;48:1727–1728
  16. Diokno AC, Dimaculangan RR, Lim EJ, Steinert BW. Office based criteria for predicting type II stress incontinence without further evaluation studies. J Urol. 1999;161:1263–1267
  17. Abrams P, Cardozo L, Khoury S, Wein A (Eds.), Incontinence. 2nd International Consultation on Incontinence, 2nd edn. Plymouth (UK): Plymbridge Distributors, Ltd. 2002. Also, available at http://www.continet.org/documents/ici_pdfs/menus/main.pdf
  18. Duncan PW, Horner RD, Reker DM, Samsa GP, Hoenig H, Hamilton B, et al.  Adherence to postacute rehabilitation guidelines is associated with functional recovery in stroke. Stroke. 2002;33:167–178
  19. Lucarelli CD. Formulary management strategies for type 3 serotonin receptor antagonists. Am J Health Syst Pharm. 2003;60(10 suppl. 1):S4–S11
  20. Szekendi MK. American College of Cardiology, American Heart Association: Compliance with acute MI guidelines lowers inpatient mortality. J Cardiovasc Nurs. 2003;18(5):356–359
  21. Frantz RA, Xakellis GC, Harvey PC, Lewis AR. Implementing an incontinence management protocol in long-term care. Clinical outcomes and costs. J Gerontol Nurs. 2003;29:46–53
  22. Viktrup L, Summers KH, Dennett SL. Clinical practice guidelines for initial management of urinary incontinence in women: An European-focused review. BJU Int. 2004;94(Suppl 1):14–22
  23. Agency for Healthcare Research and Quality (AHRQ) National Guideline Clearinghouse. Accessed on January 22, 2004 at http://www.guideline.gov/
  24. Fantl JA, Newman DK, Colling J. Urinary Incontinence in Adults: Acute and Chronic Management. Clinical Practice Guideline No. 2, 1996 Update. Rockville, MD: U.S. Department of Health and Human Services. Public Health Service, Agency for Health Care Policy and Research. AHCPR Publication No. 96-0682. March 1996
  25. Agency for Healthcare Research and Quality (AHRQ): Reauthorization Fact Sheet. AHRQ Publication No. 00-P002, December 1999. Rockville, MD: Agency for Healthcare Research and Quality. Accessed January 22, 2004 at http://www.ahrq.gov/about/ahrqfact.htm
  26. Agency for Healthcare Research and Quality (AHRQ): Frequently Asked Questions. July 2003. Rockville, MD: Agency for Healthcare Research and Quality. Accessed January 22, 2004 at http://www.ahrq.gov/faq.htm#guidelines
  27. American Academy of Family Physicians (AAFP): Urinary incontinence: Assessment and management in family practice. 2002. Accessed January 14, 2004 at http://www.aafp.org/PreBuilt/videocme/urinary_mono.pdf
  28. American Urological Association Female Stress Urinary Incontinence Clinical Guidelines Panel: The surgical management of female stress urinary incontinence. Clinical practice guidelines. 1997. Accessed September 4, 2003 at http://shop.auanet.org/timssnet/products/clinical_guidelines/FSUIptguide.pdf
  29. American Medical Directors Association (AMDA): Urinary incontinence. Columbia, MD: American Medical Directors Association; 1996. 16 pp. Accessed July 21, 2003 at http://www.guideline.gov/summary/summary.aspx?doc_id=1812&nbr=1038&string=incontinence.
  30. American College of Obstetrics and Gynecology (ACOG): ACOG criteria set. Surgery for genuine stress incontinence due to urethral hypermobility. Int J Gynaecol Obstet 1996; 52: 211–212
  31. Donovan J, Badia X, Corcos J, Goton M, Kelleher C, Naughton M, et al.  Symptom and quality of life assessment. In:  Abrams P,  Cardozo L,  Khoury S,  Wein A editor. Incontinence. Second ed. Plymouth, UK: Health Publication Ltd; 2002;p. 267–316
  32. Norton PA, Zinner NR, alcin I, Bump RC. Duloxetine vs. placebo in the treatment of stress urinary incontinence. Am J Obstet Gynecol. 2002;187:40–48
  33. Dmochowski RR, Miklos JR, Norton PA, Zinner NR, Yalcin I, Bump RC. (Duloxetine Urinary Incontinence Study Group) Duloxetine vs. placebo for the treatment of North American women with stress urinary incontinence. J Urol. Oct., 2003;170(4 Pt 1):1259–1263
  34. Stephenson J. FDA orders estrogen safety warnings: Agency offers guidance for HRT use. J Am Med Assoc. Feb 2003;289(5):537–538
  35. US Food and Drug Administration: FDA News 2004; P04-18. Accessed February 10, 2004 at http://www.fda.gov/bbs/topics/NEWS/2004/NEW01022.html
  36. Kernan WN, Viscoli CM, Brass LM, Broderick JP, Brott T, Feldmann E, et al.  Phenylpropanolamine and the risk of hemorrhagic stroke. N Engl J Med. 2000;343:1826–1832
  37. Flemming GA. The FDA, regulation and the risk of stroke (editorial). N Engl J Med. 2000;343:1886–1887
  38. Andrews JO, Tingen MS, Waller JL, Harper RJ. Provider feedback improves adherence with AHCPR smoking cessation guideline. Prev Med. 2001;33(5):415–421
  39. Albakri EA, Richards F, Hall M, Miranda LS, Turkel R, Sand C, et al.  Cooperative efforts to improve compliance with acute stroke guidelines. South Med J. 2003;96(1):23–26
  40. Kirkman MS, Williams SR, Caffrey HH, Marrero DG. Impact of a program to improve adherence to diabetes guidelines by primary care physicians. Diabetes Care. 2002;25(11):1946–1951
  41. Tierney WM, Overhage M, Murray MD, Harris LE, Zhou X, Eckert GJ, et al.  Effects of computerized guidelines for managing heart disease in primary care. J Gen Intern Med. 2004;18(12):967–976
  42. Hesdorffer DC, Ghajar J, Iacono L. Predictors of compliance with the evidence-based guidelines for traumatic brain injury care: A survey of United States trauma centers. J Trauma. 2002;52(6):1202–1209
  43. Antguaco TL, Oprescu FG, Lal SK, Pennington JH, Russel BD, Co JM, et al.  Universal precautions guideline: self-reported compliance by gastroenterologists and gastrointestinal endoscopy nurses – a decades lack of progress. Am Gastroenterol. 2003;98(11):2420–2423
  44. Clause SL, Hamilton RA. Medicaid prescriber compliance with Joint National Committee VI hypertension treatment guidelines. Ann Pharmacother. 2002;36(10):1505–1511
  45. Bland DR, Dugan E, Cohen SJ, Preisser J, Davis CC, McGann PE, et al.  The effects of implementation of the agency for health care policy and research urinary incontinence guidelines in primary care practices. J Am Geriatr Soc. 2003;51:979–984
  46. Viktrup L, Moller LA. The handling of urinary incontinence in Danish general practices after distribution of guidelines and voiding diary reimbursement. BMC;2004 (in press)
  47. Mason J, Freemantle N, Browning G. Impact of Effective Health Care bulletin on treatment of persistent glue ear in children: time series analysis. BMJ. 2001;323:1096–1097
  48. Leape LL, Weissman JS, Schneider EC, Piana RN, Gatsonis C, Epstein AM. Adherence to practice guidelines: The role of specialty society guidelines. Am Heart J. 2003;145(1):19–26
  49. O'Brien T, Freemantle N, Osman AD, Wolf F, Davis DA, Herrin J. Continuing education meetings and workshops: Effects on professional practice and health care outcomes. Cochrane Database Syst Rev. 2001;(2):D003030
  50. Hobbs FDR, Erhardt L. Acceptance of guideline recommendations and perceived implementation of coronary heart disease prevention among primary care physicians in five European countries: The Reassessing European Attitudes about Cardiovascular Treatment (REACT) survey. Fam Pract. 2002;19(6):596–604
  51. Frankel HL, FitzPatrick MK, Gaskell S, Hoff WS, Rotondo MF, Schwab CW. Strategies to improve compliance with evidence-based clinical management guideline. J Am Coll Surg. 1999;189:533–538
  52. Lanier DC, Roland M, Burstin H, Knottnerus JA. Doctor performance and public accountability. Lancet. 2003;362(9393):1404–1408
  53. Coomarasamy A, Ola B, Gee H. UK Royal College of Obstetricians and Gynaecologists. J Obstet Gynaecol. 2003;23(5):479–483
  54. Silagy CA, Stead LF, Lancaster T. Use of systematic reviews in clinical practice guidelines: case study of smoking cessation. BMJ. 2001;323:833–836
  55. Collier J, Picton C, Littlejohns P. Coordinating locally ‘owned' treatment guidelines. J R Coll Physicians Lond. 1994;28(6):519–522
  56. National Institute for Clinical Excellence (NICE): The Guideline Development Process: Information for Stakeholders. London, UK: Oaktree Press. 2001. Accessed October 27, 2003 at www.nice.org.uk
  57. Academy of Managed Care Pharmacy (AMCP): Format for Formulary Submissions, Version 2.0. 2002. Accessed October 27, 2003 at http://www.fmcpnet.org/data/resource/formatv20.pdf
  58. Shekelle PG, Oritz E, Morton SC, Eccles MP, Martin E, Grinshaw J, et al.  Validity of the agency for healthcare research and quality clinical practice guidelines: how quickly do guidelines become outdated?. J Am Med Assoc. 2001;286(12):1461–1467

PII: S0020-7292(04)00182-1

doi: 10.1016/j.ijgo.2004.05.008

International Journal of Gynecology & Obstetrics
Volume 86 , Pages S25-S37 , July 2004

Article Tools